Karolinska Developments portföljbolag Dilafor presenterar övergripande resultat från en fas 2b studie med tafoxiparin
October 31, 2018 12:15 ET
|
Karolinska Development AB (publ)
STOCKHOLM, 31 oktober 2018. Karolinska Development (Nasdaq Stockholm: KDEV) presenterar i dag övergripande studieresultat från portföljbolaget Dilafors fas 2b studie med tafoxiparin vid behandling...
Karolinska Development's portfolio company Dilafor presents top line results from a Phase 2b study with tafoxiparin
October 31, 2018 12:15 ET
|
Karolinska Development AB (publ)
STOCKHOLM, October 31, 2018. Karolinska Development (Nasdaq Stockholm: KDEV) announces today top line results from a Phase 2b study with tafoxiparin in treatment of protracted labor. The results...
Karolinska Development's portfolio company OssDsign announces FDA clearance for Cranioplug
October 22, 2018 03:00 ET
|
Karolinska Development AB (publ)
STOCKHOLM, October 22, 2018. Karolinska Development's portfolio company OssDsign announces that its latest product Cranioplug has received 510(k) clearance by the FDA, which allows marketing and...
Karolinska Development's portfolio company OssDsign announces FDA clearance for Cranioplug
October 22, 2018 03:00 ET
|
Karolinska Development AB (publ)
STOCKHOLM, October 22, 2018. Karolinska Development's portfolio company OssDsign announces that its latest product Cranioplug has received 510(k) clearance by the FDA, which allows marketing and...
Karolinska Development's portfolio company Pharmanest changes name and signs licensing agreement
October 15, 2018 07:25 ET
|
Karolinska Development AB (publ)
STOCKHOLM, October 15, 2018. Karolinska Development's portfolio company Phamanest changes its name to Palette Life Sciences. The company also announces a global licensing agreement with Nestlé Skin...
Karolinska Development's portfolio company Pharmanest changes name and signs licensing agreement
October 15, 2018 07:25 ET
|
Karolinska Development AB (publ)
STOCKHOLM, October 15, 2018. Karolinska Development's portfolio company Phamanest changes its name to Palette Life Sciences. The company also announces a global licensing agreement with Nestlé...
Karolinska Development's portfolio company Asarina Pharma is listed on Nasdaq First North
September 24, 2018 02:00 ET
|
Karolinska Development AB (publ)
STOCKHOLM, 24 September 2018. Karolinska Development's portfolio company Asarina Pharma will today be listed on Nasdaq First North in Stockholm. In connection with the listing, Asarina Pharma is...
Karolinska Development's portfolio company Asarina Pharma is listed on Nasdaq First North
September 24, 2018 02:00 ET
|
Karolinska Development AB (publ)
STOCKHOLM, 24 September 2018. Karolinska Development's portfolio company Asarina Pharma will today be listed on Nasdaq First North in Stockholm. In connection with the listing, Asarina Pharma is...
Vesalius Biocapital III Partners invests in Karolinska Development's portfolio company Forendo Pharma
September 05, 2018 03:00 ET
|
Karolinska Development AB (publ)
STOCKHOLM, September 5, 2018. Karolinska Development's portfolio company Forendo Pharma announces today that Vesalius Biocapital III Partners (Vesalius) joins Forendo Pharma's existing international...
Vesalius Biocapital III Partners invests in Karolinska Development's portfolio company Forendo Pharma
September 05, 2018 03:00 ET
|
Karolinska Development AB (publ)
STOCKHOLM, September 5, 2018. Karolinska Development's portfolio company Forendo Pharma announces today that Vesalius Biocapital III Partners (Vesalius) joins Forendo Pharma's existing international...